Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration

Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration

Zusammenfassung Dissertation zur Erlangung des akademischen Grades Dr. med. Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration eingereicht von Roland Gib, geboren am 17.01.1981 in Homburg/Saar angefertigt an der: Klinik und Poliklinik für Augen...

Full description

Bibliographic Details
Main Author:	Gib, Roland
Other Authors:	Universität Leipzig, Medizinische Fakultät
Format:	Doctoral Thesis
Language:	deu
Published:	Universitätsbibliothek Leipzig 2013
Subjects:	Avastin Bevacizumab Makuladegeneration AMD ddc:610
Online Access:	http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-126191 http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-126191 http://www.qucosa.de/fileadmin/data/qucosa/documents/12619/20131023%20Dissertation%20Roland%20Beschluss%20%C3%BCber%20die%20Verleihung.pdf

Similar Items

Progressionsrisiko früher Altersabhängiger Makuladegeneration anhand der Fundusautofluoreszenzmessung
by: Peters, David Alexander
Published: (2015)

Ergebnisse der Behandlung mit Bevacizumab bei altersabhängiger Makuladegeneration mit subfovealer Neovaskularisationsmembran über 3 bis 12 Monate
by: Walter, Lena
Published: (2011)

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
by: Raghuram A, et al.
Published: (2007-01-01)

Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos
by: Luiz Felipe de Moraes Barros
Published: (2006)

Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos
by: Barros, Luiz Felipe de Moraes
Published: (2006)

Utilización del bevacizumab en la neovascularización corneal Use of Bevacizumab in corneal neovascularization
by: Taimi Cárdenas Díaz, et al.
Published: (2012-12-01)

Uso de bevacizumab (avastin) sublesional en papilomatosis laríngea recurrente Sublesional use of bevacizumab (avastin) in recurrent laryngeal papillomatosis
by: Olenka Alcas Arce, et al.
Published: (2016-10-01)

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
by: Kai Huang, et al.
Published: (2021-06-01)

Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
by: Prashant Jain, et al.
Published: (2017-01-01)

Einfluss von Risikofaktoren auf den Behandlungserfolg von VEGF-Inhibitoren bei altersabhängiger Makuladegeneration
by: Menger, Johannes
Published: (2013)

Clinical observation of bevacizumab(avastin)for treating age-related macular degeneration
by: Zhi-Guang Duan, et al.
Published: (2014-06-01)

Intravítrea de bevacizumab en el edema macular secundario a oclusión venosa de rama retiniana
by: Caridad Chiang Rodríguez, et al.

Rökningens betydelse för uppkomst och utveckling av åldersrelaterad makuladegeneration
by: Wahlgren, Ida
Published: (2010)

Größenänderung der subretinalen Membran / der Makulanarbe nach subretinaler Chirurgie bei altersabhängiger Makuladegeneration, im Vergleich zum Verlauf nach Laserbehandlung und ohne Therapie
by: Mieck, Sibylle
Published: (2009)

The Advantage of Bevacizumab in Treating Colorectal Brain Metastasis
by: Hung-Ming Chen, et al.
Published: (2014-09-01)

Tremendous result of bevacizumab in malignant hypertensive retinopathy
by: Ali M Al-Halafi
Published: (2015-01-01)

Inyección intravítrea de bevacizumab vs. acetato de triamcinolona en el edema macular secundario a oclusión de rama venosa retiniana
by: Caridad Chiang Rodríguez, et al.

Kurz- und Langzeitergebnisse der Photodynamischen Therapie mit Verteporfin bei altersbedingter Makuladegeneration
by: Beisel, Sebastian Karl
Published: (2008)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
by: Luiz F.M. Barros, et al.
Published: (2007-09-01)

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study
by: M. Yu. Fedyanin, et al.
Published: (2021-06-01)

Wirksamkeit von Ranibizumab bei Patienten mit Chorioidaler Neovaskularisation (CNV) bei altersabhängiger Makuladegeneration (AMD) -RABIMO-
by: Bretag, Mirko
Published: (2018)

Intravitreal bevacizumab for treatment of central serous chorioretinopathy
by: Cihan Ünlü, et al.
Published: (2016-01-01)

Mögliche Korrelation zwischen dem Stadium der altersabhängigen Makuladegeneration und der zentralen Hornhautdicke
by: Koch, Christian
Published: (2016)

Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
by: Wang Zhi, et al.
Published: (2014-05-01)

An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
by: Vivek Pravin Dave, et al.
Published: (2016-01-01)

Long-Term Follow-Up of Intravitreal Bevacizumab in Retinal Arterial Macroaneurysm: A Case Report
by: Shani Golan, et al.
Published: (2011-12-01)

Klassifikation von Frühstadien der trockenen Makuladegeneration mittels Fundusautofluoreszenz
by: Mlynski, Juliane
Published: (2011)

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
by: Yuankai Shi, et al.
Published: (2021-09-01)

Effect Of Bevacizumab On Growth Of Human Nasal Polyposis In Vitro; An Off-Label Use Of Anti-Angiogenic Agent For Nasal Polyposis Treatment
by: Nemati S, et al.
Published: (2019-09-01)

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Retrospektive Studie zur Wirksamkeit der intravitrealen Bevacizumabbehandlung bei diabetischer Retinopathie und retinalem Venenverschluss
by: Schneider, Michael
Published: (2011)

AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
by: Mark-Oliver Zahn, et al.
Published: (2019-05-01)

A study on the contamination of injection bevacizumab on storage of multidose vials
by: Ketan Saoji, et al.
Published: (2018-01-01)

Indocyanine Green Mediated Photothrombosis and High Dose Intravitreal Bevacizumab as Adjuvant Therapy for Isolated Choroidal Metastasis from Breast Cancer
by: J Fernando Arevalo, et al.
Published: (2012-01-01)

Results of combined antiangiogenic activity on corneal neovascularization. Experimental and morphological study
by: V. R. Mamikpnyan, et al.
Published: (2014-09-01)

Immediate sequential bilateral intravitreal injections: an Indian perspective
by: Tripathy K
Published: (2017-04-01)

Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity
by: Fei Feng, et al.
Published: (2014-08-01)

Revisión con agujas y uso de bevacizumab en bulas de filtración encapsuladas
by: Francisco Yunier Fumero González, et al.

Uso do bevacizumab (Avastin®) na síndrome KID: relato de caso Use of bevacizumab (Avastin®) in KID syndrome: case report
by: Luiza Caye, et al.
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_vvq19dshkqleef220qd96kgat2